The Quest Laboratories IPO is a significant event in the pharmaceutical sector. The company, which specializes in manufacturing a range of antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more¹²³⁴, is offering a fresh issue of 44.5 lakh shares, amounting to Rs 43.16 crores.
The subscription period for the Quest Laboratories IPO begins on May 15, 2024, and concludes on May 17, 2024. The allotment of shares is anticipated to be completed by May 21, 2024. The IPO will be listed on the NSE SME platform, with a tentative listing date of May 23, 2024.
Investors can participate in the Quest Laboratories IPO at a price band of ₹93 to ₹97 per share. The minimum lot size for retail investors is 1200 shares, requiring an investment of ₹116,400. High Net Worth Individuals (HNIs) can invest a minimum of ₹232,800 for 2 lots, equivalent to 2,400 shares.
Shreni Shares Limited is the lead manager for the Quest Laboratories IPO, ensuring the smooth running of the book. Bigshare Services Pvt Ltd is the registrar for the issue, handling all administrative aspects. Rikhav Securities is the market maker for the Quest Laboratories IPO, providing liquidity and stability to the shares post-listing.
Stay tuned for more updates on the Quest Laboratories IPO and don’t miss the chance to invest in the future of Quest Laboratories, a key player in the pharmaceutical sector.
IPO Details :
| Company Name | Quest Laboratories |
| Sector | Pharmaceutical |
| IPO Type | SME |
| IPO Open date | 15th May 2024 |
| IPO Close date | 17th May 2024 |
| OFS | |
| Listing Exchanges | NSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 1200 | 1,16,400 |
| HNI (Min) | 2 | 2000 | 2,32,800 |
IPO Timeline:
| IPO Open Date | 15th May 2024 |
| IPO Close Date | 17th May 2024 |
| Basis of Allotment | 21st May 2024 |
| Refund Initiation Date | 22nd May 2024 |
| Shares Credit to Demat | 22 May 2024 |
| Listing Date | 23rd May 2024 |
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
